Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Addex Therapeutics (ADXN)
NASDAQ:ADXN
Addex Therapeutics (ADXN) Stock Price & Analysis
39 Followers
ADXN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.55 - $5.45
Previous Close$1.13
Volume46.77K
Average Volume (3M)336.37K
Market Cap
$19.05M
Enterprise Value$9.01M
Total Cash (Recent Filing)SFr.10.43M
Total Debt (Recent Filing)SFr.447.11K
Price to Earnings (P/E)-0.3
Beta1.20
Next Earnings
Mar 30, 2023EPS Estimate
-$0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.56
Shares Outstanding19,224,718
10 Day Avg. Volume183,053
30 Day Avg. Volume336,373
Standard Deviation0.29
R-Squared0.17
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)2.53
Price to Sales (P/S)26.87
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-1.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Addex Therapeutics News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ADXN FAQ
What was Addex Therapeutics’s price range in the past 12 months?
Addex Therapeutics lowest stock price was $0.55 and its highest was $5.45 in the past 12 months.
What is Addex Therapeutics’s market cap?
Currently, no data Available
When is Addex Therapeutics’s upcoming earnings report date?
Addex Therapeutics’s upcoming earnings report date is Mar 30, 2023 which is tomorrow.
How were Addex Therapeutics’s earnings last quarter?
Addex Therapeutics released its earnings results on Nov 11, 2022. The company reported $0.571 earnings per share for the quarter, beating the consensus estimate of -$0.093 by $0.664.
Is Addex Therapeutics overvalued?
According to Wall Street analysts Addex Therapeutics’s price is currently Overvalued.
Does Addex Therapeutics pay dividends?
Addex Therapeutics does not currently pay dividends.
What is Addex Therapeutics’s EPS estimate?
Addex Therapeutics’s EPS estimate is -$0.05.
How many shares outstanding does Addex Therapeutics have?
Addex Therapeutics has 19,224,718 shares outstanding.
What happened to Addex Therapeutics’s price movement after its last earnings report?
Addex Therapeutics reported an EPS of $0.571 in its last earnings report, beating expectations of -$0.093. Following the earnings report the stock price went up 1.299%.
Which hedge fund is a major shareholder of Addex Therapeutics?
Among the largest hedge funds holding Addex Therapeutics’s share is New Leaf Venture Partners, L.L.C.. It holds Addex Therapeutics’s shares valued at N/A.
---
Addex Therapeutics Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 50.0K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-73.53%
12-Months-Change
Fundamentals
Return on Equity
-204.04%
Trailing 12-Months
Asset Growth
-35.76%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Addex Therapeutics
Addex Therapeutics Ltd is a biopharmaceutical company. The company operates through single segment which includes developing drugs to improve human health. It is focused on the development of novel, orally available, small molecule allosteric modulators for neurological disorders. In addition, it is also engaged in the development of the dipraglurant and ADX71441 program. The company's geographical area of operations includes Switzerland and Europe.
---
---